Scientific articles 18 Nov 2021 Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection Journal of Clinical Microbiology
Scientific articles 17 Nov 2021 Towards the elimination of visceral leishmaniasis as a public health problem in East Africa: reflections on an enhanced control strategy and a call for action The Lancet Global Health
In the media 16 Nov 2021 Malaysia hopes to become Asia’s treatment hub for hepatitis C; offering treatment at fraction of cost: Health minister Channel News Asia
Stories 10 Nov 2021 MycetOS: Harnessing the power of open source to develop treatments for a most neglected disease
In the media 6 Nov 2021 Los nuevos aliados de los fármacos contra las enfermedades desatendidas El País
In the media 4 Nov 2021 Alphabet has a new drug discovery company building on DeepMind’s AI chops STAT
Press releases 4 Nov 2021 GHIT Fund expands support for DNDi Chagas disease drug discovery programmes
Stories 29 Oct 2021 Pip Stewart on cutaneous leishmaniasis: ‘It wasn’t just the parasite that got under my skin, it was the injustice of it’
Scientific articles 28 Oct 2021 DNDI-6148: A novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis Journal of Medicinal Chemistry
Scientific articles 28 Oct 2021 Chagas disease drug discovery in Latin America – A mini review of antiparasitic agents explored between 2010 and 2021 Frontiers in Chemistry
In the media 16 Nov 2021 Malaysia hopes to become Asia’s treatment hub for hepatitis C; offering treatment at fraction of cost: Health minister Channel News Asia
In the media 6 Nov 2021 Los nuevos aliados de los fármacos contra las enfermedades desatendidas El País
In the media 4 Nov 2021 Alphabet has a new drug discovery company building on DeepMind’s AI chops STAT
In the media 17 Oct 2021 Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again CNN
In the media 15 Oct 2021 Renforcement des capacités et amélioration des infrastructures des prestations de services THA au niveau périphérique RTNC
In the media 14 Oct 2021 Molnupiravir, el antiviral oral contra el COVID-19 que logró reducir un 50% el riesgo en casos graves Infobae
In the media 12 Oct 2021 Rush to buy Merck’s Covid pill risks leaving poor countries behind Bloomberg
In the media 12 Oct 2021 ‘Therapeutics nationalism’? Poor at risk of being left behind as rich buy up new Covid drug Common Dreams
In the media 8 Oct 2021 Equitable access to Covid-19 diagnostics and therapeutics is key to ending the pandemic Peoples Dispatch
